3.8 Article

Initial trials of anti-CD80 monoclonal antibody (Galiximab) therapy for patients with relapsed or refractory follicular lymphoma

Journal

CLINICAL LYMPHOMA
Volume 3, Issue 4, Pages 257-259

Publisher

CANCER INFORMATION GROUP, LP
DOI: 10.3816/CLM.2003.n.008

Keywords

B cells; CD80; immunotherapy; non-Hodgkin's lymphoma; Primatized (R); rituximab

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available